Immuneering (IMRX) Non-Current Assets (2020 - 2026)

Immuneering's Non-Current Assets history runs 7 years deep, the most recent figure standing at $53.4 million for Q1 2026.

• In Q1 2026, Non-Current Assets rose 328.06% year-over-year to $53.4 million; the TTM figure through Mar 2026 stood at $133.4 million (up 155.11% YoY), while the FY2025 annual figure was $55.7 million, up 324.62% from the prior year.
• Non-Current Assets was $53.4 million for Q1 2026 at Immuneering, down from $55.7 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $55.7 million in Q4 2025 to a low of $12.0 million in Q3 2025.
• Historically, Non-Current Assets has averaged $18.0 million across 5 years, with a median of $13.4 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Non-Current Assets jumped 702.36% in 2022, then decreased 10.1% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $13.6 million in 2022, then fell by 0.88% to $13.5 million in 2023, then retreated by 2.77% to $13.1 million in 2024, then surged by 324.62% to $55.7 million in 2025, then dropped by 4.2% to $53.4 million in 2026.
• The last three Non-Current Assets figures came in at $53.4 million (Q1 2026), $55.7 million (Q4 2025), and $12.0 million (Q3 2025), per Business Quant data.